U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Guidelines and Recommendations

CDC Stacks Public Health Publications

CDC Guidelines and Recommendations are updated by various CDC centers and institutes in response to new scientific discoveries, to public health issues, and to disease outbreaks. Items in this collection may have been superceded or replaced. For the most up to date information, please visit the CDC home page at https://www.cdc.gov/ and search the Health Topic or Outbreak you are interested in.

(5)
(2)
(4)
(3)
(2)
(3)
(17)
(10)
(16)
(13)
(27)
(33)
(21)
(46)
(33)
(34)
(34)
(22)
(25)
(18)
(19)
(27)
(21)
(29)
(13)
(15)
(17)
(14)
(12)
(10)
(13)
(15)
(12)
(14)
(11)
(16)
(16)
(6)
(1)
(3)
(3)
(6)
(3)
(1)
(4)
(27)
(22)
(30)
(8)
(9)
(7)
(7)
0 of 52
(123)
(27)
(1)
(1)
(626)
0 of 5
(1)
(1)
(3)
(2)
(1)
(30)
(1)
(7)
(1)
(3)
(7)
(1)
(1)
(1)
(104)
(1)
(1)
(7)
(3)
(2)
(1)
(1)
(45)
(1)
(117)
(8)
(51)
(2)
(29)
(5)
(4)
(1)
(1)
(1)
(2)
(413)
(2)
(5)
(13)
(2)
(1)
0 of 41
(7)
(2)
(39)
(3)
(2)
(2)
(7)
0 of 7
(53)
(6)
(5)
(1)
(3)
(12)
(563)
(1)
(1)
(22)
(41)
(63)
0 of 12
(449)
(1)
(31)
(270)
(1)
0 of 5
(130)
(18)
0 of 2
(138)
(9)
(1)
0 of 3
(2)
(1)
(9)
(8)
(6)
(2)
(1)
(1)
(1)
(1)
(14)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(2)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(2)
(2)
(74)
(1)
(5)
(1)
(1)
(1)
(87)
(1)
(1)
(7)
(1)
(4)
(35)
(2)
(9)
(1)
(5)
(2)
(1)
(8)
(3)
(3)
(7)
(1)
(2)
(1)
(1)
(2)
(2)
(2)
(29)
(1)
(8)
(20)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(36)
(6)
(1)
(6)
(3)
(13)
(2)
(2)
(1)
(5)
(1)
(1)
(2)
(1)
(8)
(1)
(2)
(1)
(8)
(1)
(3)
(3)
(1)
(8)
(5)
(1)
(1)
(2)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(14)
(3)
(4)
(1)
(2)
(1)
(3)
(6)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(6)
(10)
(1)
(10)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(8)
(1)
(1)
(1)
(4)
(2)
(4)
(9)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(2)
(6)
(1)
(3)
(1)
(3)
(1)
(2)
(13)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(22)
(2)
(13)
(3)
(1)
(2)
(1)
(4)
(2)
(4)
(1)
(1)
(1)
(4)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(6)
(3)
(1)
(1)
(1)
(3)
(3)
(1)
(1)
(6)
(2)
(2)
(1)
(91)
(76)
(3)
(1)
(1)
(1)
(2)
(4)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(11)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(3)
(3)
(2)
(2)
(6)
(2)
(3)
(9)
(2)
(5)
(2)
(3)
(4)
(14)
(3)
(2)
(10)
(4)
(3)
(4)
(3)
(4)
(6)
(2)
(2)
(2)
(2)
(11)
(2)
(2)
(10)
(3)
(2)
(4)
(4)
(5)
(3)
(2)
(2)
(2)
(11)
(10)
(2)
(15)
(6)
(3)
(3)
(2)
(3)
(2)
(5)
(3)
(3)
(2)
(7)
(2)
(2)
(2)
(3)
(3)
(2)
(8)
(5)
(2)
(2)
(2)
(2)
(2)
(3)
(10)
(10)
(2)
(2)
(2)
(3)
(2)
(15)
(2)
(4)
(2)
(6)
(24)
(20)
(18)
(2)
(5)
(2)
(7)
(3)
(2)
(5)
(8)
(2)
(2)
(3)
(7)
(2)
(2)
(5)
(3)
(9)
(11)
(2)
(3)
(2)
(2)
(4)
(4)
(6)
(2)
(2)
(2)
(2)
(4)
(3)
(2)
(25)
(2)
(15)
(2)
(3)
(5)
(31)
(2)
(2)
(5)
(2)
(3)
(15)
(2)
(3)
(5)
(4)
(7)
(2)
(2)
(2)
(4)
(4)
(6)
(3)
(5)
(2)
(3)
(3)
(4)
(64)
(2)
(2)
(3)
(2)
(3)
(2)
(2)
(2)
(4)
(3)
(2)
(3)
(4)
(2)
(3)
(2)
(2)
(2)
(4)
(2)
(4)
(2)
(3)
(3)
(2)
(2)
(2)
(3)
(13)
(8)
(2)
(77)
(3)
(10)
(7)
(3)
(4)
(21)
(2)
(3)
(5)
(13)
(4)
(2)
(2)
(2)
(3)
(3)
(2)
(2)
(4)
(4)
(2)
(5)
(3)
(3)
(3)
(2)
(4)
(2)
(8)
(4)
(2)
(2)
(8)
(4)
(5)
(2)
(2)
(2)
(2)
(9)
(7)
(6)
(2)
(3)
(3)
(43)
(2)
(3)
(2)
(4)
(2)
(5)
(2)
(2)
(11)
(11)
(6)
(4)
(6)
(6)
(6)
(2)
(2)
(2)
(5)
(221)
(12)
(2)
(2)
(2)
(2)
(10)
(7)
(2)
(18)
(2)
(2)
(7)
(7)
(4)
(9)
(98)
(2)
(2)
(10)
(2)
(2)
(4)
(2)
(3)
(5)
(83)
(30)
(2)
(31)
(7)
(2)
(8)
(2)
(7)
(3)
(4)
(5)
(20)
(10)
(9)
(3)
(14)
(6)
(2)
(12)
(4)
(11)
(2)
(10)
(2)
(16)
(5)
(2)
(2)
(21)
(18)
(3)
(8)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(3)
(5)
(3)
(3)
(5)
(2)
(2)
(10)
(2)
(5)
(12)
(2)
(5)
(2)
(3)
(2)
(14)
(3)
(3)
(3)
(3)
(3)
(2)
(5)
(2)
(4)
(2)
(2)
(13)
(3)
(4)
(4)
(11)
(11)
(2)
(42)
(4)
(28)
(2)
(2)
(16)
(3)
(9)
(5)
(8)
(9)
(2)
(2)
(9)
(15)
(2)
(11)
(7)
(2)
(2)
(2)
(3)
(43)
(2)
(6)
(4)
(2)
(4)
(8)
(8)
(8)
(5)
(2)
(9)
(6)
(7)
(2)
(4)
(3)
(6)
(2)
(2)
(27)
(2)
(140)
(164)
(2)
(4)
(3)
(2)
(2)
(5)
(4)
(4)
(10)
(4)
(11)
(5)
(6)
(5)
(2)
(2)
(35)
(5)
(3)
(2)
(2)
(4)
(2)
(4)
(4)
(10)
(3)
(2)
(4)
(2)
(11)
(2)
(2)
(5)
(2)
(3)
(5)
(23)
(3)
(6)
(2)
(2)
(3)
(2)
(22)
(6)
(3)
(60)
(3)
(23)
(2)
(4)
(5)
(2)
(2)
(2)
(6)
(2)
(2)
(2)
(15)
(2)
(2)
(2)
(6)
(2)
(12)
(2)
(14)
(5)
(5)
(4)
(4)
(3)
(18)
(9)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(7)
(3)
(2)
(18)
(2)
(2)
(16)
(3)
(3)
(10)
(2)
(6)
(2)
(7)
(3)
(2)
(3)
(5)
(7)
(10)
(2)
(18)
(22)
(5)
(3)
(2)
(7)
(12)
(29)
(41)
(3)
(4)
(2)
(2)
(2)
(3)
(2)
(3)
(5)
(165)
(23)
(7)
(3)
(3)
(10)
(2)
(6)
(2)
(2)
(3)
(2)
(6)
(4)
(6)
(2)
(2)
(2)
(2)
(17)
(3)
(4)
(2)
(5)
(3)
(2)
(2)
(7)
(3)
(2)
(13)
(5)
(6)
(2)
(4)
(2)
(2)
(2)
(2)
(4)
(19)
(15)
(7)
(3)
(6)
(4)
(3)
(2)
(3)
(3)
(3)
(2)
(4)
(2)
(2)
(2)
(2)
(5)
(3)
(2)
(3)
(5)
(3)
(2)
(2)
(2)
(4)
(4)
(6)
(3)
(3)
(2)
(2)
(6)
(2)
(2)
(2)
(36)
(2)
(2)
(14)
(2)
(2)
(2)
(8)
(19)
(3)
(5)
(4)
(2)
(4)
(6)
(2)
(2)
(2)
(3)
(3)
(3)
(2)
(6)
(10)
(87)
(2)
(23)
(15)
(2)
(8)
(16)
(11)
(11)
(15)
(2)
(12)
(2)
(3)
(3)
(5)
(14)
(3)
(2)
(2)
(6)
(4)
(3)
(4)
(8)
(6)
(3)
(4)
(2)
(2)
(10)
(3)
(2)
(2)
(3)
(9)
(2)
(11)
(4)
(5)
(2)
(2)
(2)
(2)
(2)
(17)
(5)
(4)
(3)
0 of 1000
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(8)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(13)
(1)
(1)
(10)
(1)
(1)
(1)
(2)
(1)
(11)
(1)
(1)
(3)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(4)
(1)
(1)
(2)
(1)
(1)
(2)
(5)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(6)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(1)
(2)
(5)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(22)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(2)
(1)
(4)
(1)
(9)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(10)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(4)
(1)
(2)
(2)
(1)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(8)
(1)
(2)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(2)
(1)
(3)
(5)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(2)
(2)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(4)
(2)
(1)
(2)
(3)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(5)
(1)
(4)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(3)
(4)
(1)
(7)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(7)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(5)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(4)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(3)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(3)
(4)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(2)
(2)
(1)
(3)
(1)
(1)
(3)
(6)
(2)
(2)
(2)
(7)
(2)
(5)
(3)
(4)
(3)
(2)
(7)
(2)
(2)
(5)
(2)
(2)
(5)
(2)
(2)
(3)
(3)
(3)
(3)
(3)
(4)
(2)
(5)
(3)
(4)
(2)
(2)
(2)
(2)
(2)
(2)
(5)
(9)
(2)
(3)
(2)
(2)
(2)
(2)
(2)
(7)
(3)
(2)
(6)
(2)
(2)
(2)
(3)
(2)
(3)
(2)
(6)
(4)
(2)
(5)
(5)
(8)
(2)
(2)
(4)
(3)
(3)
0 of 1000
(1)
(6)
(1)
(1)
(3)
(19)
(1)
(3)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(12)
(17)
(8)
(1)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(4)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(26)
(1)
(2)
(1)
(1)
(4)
(22)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(276)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(6)
(1)
(1)
(4)
(1)
(1)
(2)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(7)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(13)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(2)
(4)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(11)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(3)
(2)
(1)
(1)
(3)
(1)
(4)
(2)
(4)
(5)
(2)
(5)
(2)
(3)
(1)
(22)
(1)
(3)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(8)
(1)
(1)
(2)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(5)
(1)
(1)
(1)
(1)
(10)
(1)
(3)
(1)
(4)
(4)
(4)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(7)
(6)
(4)
(9)
(18)
(1)
(2)
(1)
(1)
(1)
(4)
(6)
(1)
(1)
(4)
(3)
(1)
(1)
(1)
(4)
(1)
(1)
(15)
(6)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(4)
(1)
(2)
(1)
(8)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(6)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(8)
(3)
(7)
(1)
(1)
(144)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(8)
(1)
(3)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(3)
(12)
(122)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(4)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(9)
(1)
(1)
(3)
(1)
(1)
(1)
0 of 444
(1)
(1)
(9)
(4)
(1)
(1)
(2)
(89)
(3)
(2)
(40)
(230)
(1)
(25)
(1)
(81)
(1)
(26)
(2)
(4)
(146)
(1)
(1)
(4)
(1)
(4)
0 of 26
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
0 of 171
Showing 201 - 220 of 779 results
  • Preparedness and response for Chikungunya virus introduction in the Americas
    Preparedness and response for Chikungunya virus introduction in the Americas
    Barrera, Roberto ;
    Hunsperger, Elizabeth
    2011
    Pan American Health Organization (PAHO), with the support of the Division of Vector-borne Diseases of the United States Centers for Disease Control and Prevention (DVBD, CDC), created a working group and convened a meeting in Lima, Peru, on July 21-23, 2010, to discuss the threat this virus represents and to examine measures that might be taken to ...
    Current Multi-Language Public Domain
  • Guide for HIVAIDS clinical care
    Guide for HIV/AIDS clinical care
    United States. HIV/AIDS Bureau.  ...
    January 2011
    HIV/AIDS clinical care has improved dramatically over the decades, given the availability of new medications and a better understanding of how best to use antiretrovirals and deliver primary care to persons living with HIV/AIDS. Positive change on such a massive scale, however, brings with it new demands on clinicians. Along with innovations in HIV ...
    Current Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports December 17 2010 Vol 59 No RR12
    Morbidity and Mortality Weekly Report: Recommendations and Reports, December 17, 2010 / Vol. 59 / No. RR-12
    Workowski, Kimberly A. ;
    Berman, Stuart M.
    December 17, 2010 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    "These guidelines for the treatment of persons who have or are at risk for sexually transmitted diseases (STDs) were updated by CDC after consultation with a group of professionals knowledgeable in the field of STDs who met in Atlanta on April 18-30, 2009. The information in this report updates the 2006 Guidelines for Treatment of Sexually Transmit ...
    Superseded Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports December 10 2010 Vol 59 No RR11
    Morbidity and Mortality Weekly Report: Recommendations and Reports, December 10, 2010 / Vol. 59 / No. RR-11
    Nuorti, J. Pekka ;
    Whitney, Cynthia G.
    December 10, 2010 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    "On February 24, 2010, a 13-valent pneumococcal polysaccharide-protein conjugate vaccine (PCV13 [Prevnar 13, Wyeth Pharmaceuticals Inc., marketed by Pfizer Inc.]) was licensed by the Food and Drug Administration (FDA) for prevention of invasive pneumococcal disease (IPD) caused among infants and young children by the 13 pneumococcal serotypes cover ...
    Current Public Domain
  • How To Clean and Disinfect Schools To Help Slow the Spread of Flu 2010
    How To Clean and Disinfect Schools To Help Slow the Spread of Flu [2010]
    Centers for Disease Control and Prevention (U.S.)
    December 8, 2010
    Cleaning and disinfecting are part of a broad approach to preventing infectious diseases in schools. To help slow the spread of influenza (flu), the first line of defense is getting vaccinated. Other measures include covering coughs and sneezes, washing hands, and keeping sick people away from others. Below are tips on how to slow the spread of flu ...
    Current Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports November 19 2010 Vol 59 No RR10
    Morbidity and Mortality Weekly Report: Recommendations and Reports, November 19, 2010 / Vol. 59 / No. RR-10
    McGee, Lesley ;
    Schrag, Stephanie
    November 19, 2010 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    "Despite substantial progress in prevention of perinatal group B streptococcal (GBS) disease since the 1990s, GBS remains the leading cause of early-onset neonatal sepsis in the United States. In 1996, CDC, in collaboration with relevant professional societies, published guidelines for the prevention of perinatal group B streptococcal disease (CDC. ...
    Current Public Domain
  • How to clean and disinfect schools to help slow the spread of flu school guide
    How to clean and disinfect schools to help slow the spread of flu : school guide
    Centers for Disease Control and Prevention (U.S.)
    October, 2010
    Cleaning and disinfecting are part of a broad approach to preventing infectious diseases in schools. To help slow the spread of influenza (flu), the first line of defense is getting vaccinated. Other measures include covering coughs and sneezes, washing hands, and keeping sick people away from others. Below are tips on how to slow the spread of flu ...
    Superseded Public Domain
  • Updated recommendations for prevention of invasive pneumococcal disease among adults using PPSV23
    Updated recommendations for prevention of invasive pneumococcal disease among adults using PPSV23
    Nuorti, J. Pekka. ;
    Whitney, Cynthia G.
    September 2010 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Invasive disease from Streptococcus pneumoniae (pneumococcus) is a major cause of illness and death in the United States, with an estimated 43,500 cases and 5,000 deaths among persons of all ages in 2009. This report provides updated recommendations from the Advisory Committee on Immunization Practices (ACIP) for prevention of invasive pneumococcal ...
    Current Supporting Files Public Domain
  • Update Recommendations of the Advisory Committee on Immunization Practices ACIP regarding use of CSL seasonal influenza vaccine Afluria in the United States during 201011 MMWR 2010 59 31 989992
    Update: Recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding use of CSL seasonal influenza vaccine (Afluria) in the United States during 2010--11. MMWR 2010; 59 (31): 989-992.
    United States. Advisory Committee on Immunization Practices.
    August 13, 2010 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    During the 2010 influenza season in Australia, administration of a 2010 Southern Hemisphere seasonal influenza trivalent inactivated vaccine (TIV) (Fluvax Junior and Fluvax) manufactured by CSL Biotherapies was associated with increased frequency of fever and febrile seizures in children aged 6 months through 4 years. Postmarketing surveillance ind ...
    Superseded Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports August 6 2010 Vol 59 No RR8
    Morbidity and Mortality Weekly Report: Recommendations and Reports, August 6, 2010 / Vol. 59 / No. RR-8
    Bresee, Joseph S. ;
    Broder, Karen R.
    August 6, 2010 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    "This report updates the 2009 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine for the prevention and control of influenza (CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2009;58[No. RR-8] and CDC. Use of in ...
    Superseded Public Domain
  • Costeffectiveness of interventions to prevent and control diabetes mellitus a systematic review
    Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review
    National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Diabetes Translation.
    August 2010 | Diabetes care. 2010; 33(8):1872-94.
    OBJECTIVE: To synthesize the cost-effectiveness (CE) of interventions to prevent and control diabetes, its complications, and comorbidities.
    Current Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports July 30 2010 Vol 59 No RR7
    Morbidity and Mortality Weekly Report: Recommendations and Reports, July 30, 2010 / Vol. 59 / No. RR-7
    Fischer, Marc ;
    Gershman, Mark
    July 30, 2010 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    "This report updates CDC's recommendations for using yellow fever (YF) vaccine (CDC. Yellow fever vaccine: recommendations of the Advisory Committee on Immunizations Practices: MMWR 2002;51[No. RR-17]). Since the previous YF vaccine recommendations were published in 2002, new or additional information has become available on the epidemiology of YF, ...
    Current Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports July 23 2010 Vol 59 No RR6
    Morbidity and Mortality Weekly Report: Recommendations and Reports, July 23, 2010 / Vol. 59 / No. RR-6
    Wright, Jennifer G. ;
    Quinn, Conrad P.
    2010/07/23 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    These recommendations from the Advisory Committee on Immunization Practices (ACIP) update the previous recommendations for anthrax vaccine adsorbed (AVA) (CDC. Use of anthrax vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2000;49:1--20; CDC. Use of anthrax vaccine in response to terror ...
    Current Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports June 25 2010 Vol 59 No RR5
    Morbidity and Mortality Weekly Report: Recommendations and Reports, June 25, 2010 / Vol. 59 / No. RR-5
    Castro, Kenneth G. ;
    Goldberg, Stefan
    June 25, 2010 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    "This report updates and combines earlier versions of guidelines for the prevention and treatment of opportunistic infections (OIs) in HIV-infected adults (i.e., persons aged [more than or equal to] 18 years) and adolescents (i.e., persons aged 13--17 years), last published in 2002 and 2004, respectively. It has been prepared by the Centers for Dis ...
    Current Public Domain
  • PHIN batch specification Version 11
    PHIN batch specification [Version 1.1]
    Centers for Disease Control and Prevention (U.S.). Public Health Information Network.
    June 22, 2010
    The HL7 Batch Protocol may be employed by any implementation of HL7 messages to make messaging more efficient with the Public Health Information Network Messaging System (PHINMS). There are no restrictions on the types of messages sent in a particular batch.Due to size limitations on PHINMS, a single batch file should not exceed 10 Mb in size.The H ...
    Current Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports June 18 2010 Vol 59 No RR4
    Morbidity and Mortality Weekly Report: Recommendations and Reports, June 18, 2010 / Vol. 59 / No. RR-4
    Curtis, Kathryn M.
    June 18, 2010 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    "CDC created U.S. Medical Eligibility Criteria for Contraceptive Use, 2010, from guidance developed by the World Health Organization (WHO) and finalized the recommendations after consultation with a group of health professionals who met in Atlanta, Georgia, during February 2009. This guidance comprises recommendations for the use of specific contra ...
    Superseded Public Domain
  • FDA licensure of bivalent human papillomavirus vaccine HPV2 Cervarix for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices ACIP
    FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP)
    United States. Advisory Committee on Immunization Practices.  ...
    May 28, 2010 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    On October 16, 2009, the Food and Drug Administration (FDA) licensed bivalent human papillomavirus vaccine (HPV2; Cervarix, GlaxoSmithKline) for use in females aged 10 through 25 years. Cervarix is the second human papillomavirus (HPV) vaccine licensed for use in females in the United States. Quadrivalent HPV vaccine (HPV4; Gardasil, Merck & Co, In ...
    Current Public Domain
  • FDA licensure of quadrivalent human papillomavirus vaccine HPV4 Gardasil for use in males and guidance from the Advisory Committee on Immunization Practices ACIP
    FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP)
    United States. Advisory Committee on Immunization Practices.  ...
    May 28, 2010 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    To develop the 1993 Sexually Transmitted Diseases Treatment Guidelines, experts from the Centers for Disease Control and Prevention reviewed the literature on sexually transmitted disease treatment, assembled tables of evidence, and listed key questions on therapeutic outcome: microbiologic cure, alleviation of symptoms, and prevention of sequelae ...
    Superseded Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports May 7 2010 Vol 59 No RR3
    Morbidity and Mortality Weekly Report: Recommendations and Reports, May 7, 2010 / Vol. 59 / No. RR-3
    Marin, Mona ;
    Broder, Karen R.
    May 7, 2010 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    This report presents new recommendations adopted in June 2009 by CDC's Advisory Committee on Immunization Practices (ACIP) regarding use of the combination measles, mumps, rubella, and varicella vaccine (MMRV, ProQuad, Merck & Co., Inc.). MMRV vaccine was licensed in the United States in September 2005 and may be used instead of measles, mumps, rub ...
    Current Public Domain
  • Future Research Directions to Identify Causes of the Increasing Incidence Rate of Congenital Hypothyroidism in the United States
    Future Research Directions to Identify Causes of the Increasing Incidence Rate of Congenital Hypothyroidism in the United States
    May 2010 | Pediatrics. 2010; 125 Suppl 2:S64-8.
    A workshop to evaluate the reported increasing trend in the incidence rate of primary congenital hypothyroidism (CH) identified by newborn screening was held February 27 and 28, 2008, in Atlanta, Georgia, and was sponsored by the Centers for Disease Control and Prevention, the Health Resources and Services Administration, and the National Newborn S ...
    Current Public Domain
201 - 220 / 779